Expression of CD44 isoforms in cultured human trabecular meshwork cells

Ophthalmic Research

Volumn 30, Issue 5, 1998, Pages 314-320

  Jumper, Michele D ^a   Stern, Robert ^a   Lui, Gei Ming ^a   Formby, Bent ^b   Schwartz, Daniel M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SANSUM DIABETES RESEARCH INSTITUTE   (United States)

Author keywords

CD44; Human trabecular meshwork; Hyaluronic acid

Indexed keywords

ANTIBODY; HERMES ANTIGEN; HYALURONIC ACID;

ANTIGEN EXPRESSION; ARTICLE; CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; TRABECULAR MESHWORK;

ANTIGENS, CD44; CELLS, CULTURED; DNA PRIMERS; EXONS; HUMANS; IMMUNOENZYME TECHNIQUES; POLYMERASE CHAIN REACTION; TRABECULAR MESHWORK; TRANSCRIPTION, GENETIC;

EID: 0031820890     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000055490     Document Type: Article

References (26)

1. Picker LJ, Nakache M, Butcher EC: Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types. J Cell Biol 1989;109:927-937.
2. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI: Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992;89:12160-12164.
3. Haynes BF, Telen MJ, Hale LP, Denning SM. CD44 - A molecule involved in leukocyte adherence and T-cell activation. Immunol Today 1989;10:423-438.
4. Underhill C: CD44: The hyaluronan receptor. J Cell Sci 1992;103:293-298.
5. Gunthert U: CD44: A multitude of isoforms with diverse functions. Curr Top Microbiol Immunol 1993; 184:47-63.
6. Lesley J, Hyman R, Kincade PW: CD44 and its interaction with the extracellular matrix. Adv Immunol 1994;54:271-335.
7. Cooper DL, Dougherty GJ: To metastasize or not? Selection of CD44 splice sites. Nat Med 1995;1:635-637.
8. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B: CD44 is the principal cell surface receptor for hyaluronate. Cell 1990;61:1303-1313.
9. Miyake K, Underhill CB, Lesley J, Kincade PW: Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med 1990;172: 69-75.
10. Stamenkovic I, Aruffo A, Seed B: The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J 1991;10:343-348.
11. He Q, Lesley J, Hyman R, Ishihara K, Kincade PW: Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition. J Cell Biol 1992;119:1711-1719.
12. Knudson W, Bartnik E, Knudson CB: Assembly of pericellular matrices by COS-7 cells transfected with CD44 lymphocyte-homing receptor genes. Proc Natl Acad Sci USA 1993;90:4003-4007
13. Knudson CB: Hyaluronan receptor-directed assembly of chondrocyte pericellular matrix. J Cell Biol 1993; 120:825-834.
14. Bourguignon LY, Lokeshwar VB, Chen X, Kerrick WG: Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (Gp85/CD44)-cytoskeleton interaction. J Immunol 1993;151:6634-6644.
15. Guo YJ, Ma J, Wang JH, Lin SC, Chang HC, Bigby M, Sy MS: Monoclonal anti-CD44 antibody acts in synergy with anti-CD2 but inhibits anti-CD3 or T cell receptor-mediated signaling in murine T cell hybridomas. Cell Immunol 1993;152: 186-199.
16. Culty M, Nguyen HA, Underhill CB: The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J Cell Biol 1992;116:1055-1062.
17. Hua Q, Knudson CB, Knudson W: Internalization of hyaluronan by chondrocytes occurs via receptor-mediated endocytosis. J Cell Sci 1993;106:365-375.
18. Culty M, Shizari M, Thompson EW, Underhill CB: Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: Correlation with invasive potential. J Cell Physiol 1994;160:275-286.
19. Barany EH, Scotchbrook S: Influence of testicular hyaluronidase on the resistance to flow through the angle of the anterior chamber. Acta Phys Scand 1954;30:240-248.
20. Knepper PA, Farbman AI, Telser AG: Exogenous hyaluronidases and degradation of hyaluronic acid in the rabbit eye. Invest Ophthalmol Vis Sci 1984;25:286-293.
21. Stein R, Romano A, Treister G, Bartov E: Effect of subconjunctival injection of hyaluronidase on outflow resistance in normal and in open angle glaucomatous patients. Metab Pediatr Syst Ophthalmol 1992;6: 169-174.
22. Lindemulder SJ, Goossens W, Mayanil CSK, Knepper PA: CD44 isoforms in human trabecular meshwork (abstract) Invest Ophthalmol Vis Sci 1996;37:3790-13576.
23. Polansky JR, Weinraub RN, Baxter JD, Alvarado J: Human trabecular cells. I. Establishment in tissue culture and growth characteristics. Invest Ophthalmol Vis Sci 1979;18: 1043-1049.
24. Iida N, Bourguignon LY: New CD44 splice variants associated with human breast cancers. J Cell Physiol 1995;162:127-133.
25. Bennett KL, Jackson DG, Simon JC, Tanczos E, Peach R, Modrell B, Stamenkovic I, Plowman G, Aruffo A: CD44 isoforms containing exon V3 are responsible for the presentation of heparan-binding growth factor. J Cell Biol 1995;128:687-698.
26. Li J, Tripathi BJ, Chalam KV, Tripathi RC: Transforming growth factor-beta 1 and beta 2 positively regulate TGF-beta 1 mRNA expression in trabecular cells. Invest Ophthalmol Vis Sci 1996;37-2778-2782.